“A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis”. Al Mustansiriyah Journal of Pharmaceutical Sciences 7, no. 1 (June 1, 2010): 90–105. Accessed April 19, 2025. https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/321.